ACAD
33.72
+1.51
+4.69%
AEMD
2.25
-0.02
-0.88%
APRI
1.22
+0.02
+1.67%
ARNA
1.36
+0.06
+4.62%
ATEC
1.96
-0.04
-2.00%
CNAT
7.64
+0.1
+1.33%
CRXM
0.2
0.00
-2.20%
CYTX
1.1
+0.09
+8.91%
DXCM
74.89
-0.34
-0.45%
GNMK
12.55
+0.05
+0.40%
HALO
13.39
+0.11
+0.79%
ILMN
180.2
+4.91
+2.80%
INNV
0.095
-0.004
-3.965%
INO
6.53
+0.26
+4.15%
ISCO
1.65
-0.1
-5.71%
ISIS
57.56
0.00
0.00%
LGND
105.12
+0.73
+0.70%
LPTN
2.93
0.00
0.00%
MBVX
2.01
+0.12
+6.35%
MEIP
1.56
-0.01
-0.64%
MNOV
5.43
-0.4
-6.86%
MRTX
4.4
+0.15
+3.53%
MSTX
0.138
+0.008
+6.2308%
NBIX
51.78
+0.68
+1.33%
NUVA
76.35
+1.33
+1.77%
ONCS
1.17
-0.03
-2.4917%
ONVO
2.73
+0.02
+0.74%
OREX
2.98
+0.09
+3.11%
OTIC
12.5
+0.15
+1.21%
QDEL
23.5
-0.06
-0.25%
RCPT
231.96
0.00
0.00%
RGLS
1.4
0.00
0.00%
RMD
70.74
+0.9
+1.29%
SPHS
2.61
+0.01
+0.38%
SRNE
1.75
-0.05
-2.78%
TROV
0.88
+0.052
+6.2832%
VICL
2.369
+0.109
+4.823%
VOLC
18
0.00
0.00%
ZGNX
10.6
-0.1
-0.93%
ACAD
33.72
+1.51
+4.69%
AEMD
2.25
-0.02
-0.88%
APRI
1.22
+0.02
+1.67%
ARNA
1.36
+0.06
+4.62%
ATEC
1.96
-0.04
-2.00%
CNAT
7.64
+0.1
+1.33%
CRXM
0.2
0.00
-2.20%
CYTX
1.1
+0.09
+8.91%
DXCM
74.89
-0.34
-0.45%
GNMK
12.55
+0.05
+0.40%
HALO
13.39
+0.11
+0.79%
ILMN
180.2
+4.91
+2.80%
INNV
0.095
-0.004
-3.965%
INO
6.53
+0.26
+4.15%
ISCO
1.65
-0.1
-5.71%
ISIS
57.56
0.00
0.00%
LGND
105.12
+0.73
+0.70%
LPTN
2.93
0.00
0.00%
MBVX
2.01
+0.12
+6.35%
MEIP
1.56
-0.01
-0.64%
MNOV
5.43
-0.4
-6.86%
MRTX
4.4
+0.15
+3.53%
MSTX
0.138
+0.008
+6.2308%
NBIX
51.78
+0.68
+1.33%
NUVA
76.35
+1.33
+1.77%
ONCS
1.17
-0.03
-2.4917%
ONVO
2.73
+0.02
+0.74%
OREX
2.98
+0.09
+3.11%
OTIC
12.5
+0.15
+1.21%
QDEL
23.5
-0.06
-0.25%
RCPT
231.96
0.00
0.00%
RGLS
1.4
0.00
0.00%
RMD
70.74
+0.9
+1.29%
SPHS
2.61
+0.01
+0.38%
SRNE
1.75
-0.05
-2.78%
TROV
0.88
+0.052
+6.2832%
VICL
2.369
+0.109
+4.823%
VOLC
18
0.00
0.00%
ZGNX
10.6
-0.1
-0.93%
Home » Archive by Category

Xconomy

Dear Tom Price: Bundled Payments Help Patients and Reduce Costs

February 11, 2017 – 3:00 am

With all the talk of repealing Barack Obama’s Affordable Care Act (ACA), people have been taking a closer look at what the law has done for our healthcare system. It turns out the ACA is about a lot…

[[Click headline to continue reading.]]

Senate Confirms Price for HHS, But Stock Deals Still Raise Questions

February 10, 2017 – 5:22 am

The Senate confirmed Tom Price as Secretary of the U.S. Department of Health and Human Services early Friday morning by a 52-47 vote that, as expected, fell largely on party lines. Price is an…

[[Click headline to continue reading.]]

Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More

February 10, 2017 – 3:35 am

The biotech community pushed back against President Donald Trump’s order to block travelers and refugees this week, and not much later, a federal court did, too. Patient advocates have scored…

[[Click headline to continue reading.]]

Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation

February 10, 2017 – 3:30 am

In the biomedical world, perhaps the biggest question looming over President Donald Trump’s upcoming pick for Food and Drug Administration commissioner is how drastically that person will help…

[[Click headline to continue reading.]]

Xconomy Is Growing: We Need Great Salespeople in SF, Texas, and NY

February 9, 2017 – 9:59 am

Since Xconomy’s founding nearly a decade ago, we have grown from a single bureau in Boston to having editors covering 11 innovation clusters around the United States. And over this time, we have…

[[Click headline to continue reading.]]

Biotech Leaders Sign Letter Condemning Trump’s Travel Ban

February 7, 2017 – 6:55 am

The blowback from U.S. business leaders to President Trump’s travel ban continues—today from a throng of biotech executives. This morning, 165 U.S. biotech leaders have signed a letter voicing…

[[Click headline to continue reading.]]

Kentucky Biotech CEO’s Message For McConnell: I’ll Be Muslim, Too

February 7, 2017 – 3:00 am

President Trump’s order to bar refugees and immigrants from seven Muslim-majority countries is on temporary hold, and a court hearing later today could eventually force a ruling by the U.S….

[[Click headline to continue reading.]]

As Iraqi Immigrant, Bio CEO Sees Pros and Cons in U.S. Travel Ban

February 5, 2017 – 9:01 pm

Noori Barka came to California on an H-1B visa in 1986 to work for Santa Monica-based Specialty Laboratories, a medical diagnostics company best known for its clinical testing services. Barka said he…

[[Click headline to continue reading.]]

Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins

February 3, 2017 – 6:10 am

Folks had just clocked out last Friday when the Trump Administration announced a travel ban that threw airports around the country into chaos. That announcement set the tone for this week in life…

[[Click headline to continue reading.]]

Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing

February 2, 2017 – 12:09 pm

A team of decorated academic chemists in San Diego have been working since 2014 on a biotech startup that aims to find new drugs faster. The company now has a lot of cash in the bank and a well-known…

[[Click headline to continue reading.]]